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Abstract: Thymus herba-barona, Thymus pseudolanuginosus, and Thymus caespititius decoctions were
screened for their phenolic constituents, along with their potential antioxidant, anti-inflammatory,
and antibacterial activities. The total phenolic compounds in the extracts of the three plants
ranged from 236.0 ± 26.6 mgGAE/g (T. caespititus) to 293.0 ± 30.5 mgGAE/g of extract
(T. pseudolanuginosus), being particularly rich in caffeic acid derivatives, namely rosmarinic acid and
its structural isomers, as well as flavones, such as luteolin-O-glucuronide. The T. pseudolanuginosus
extract presented the best DPPH radical scavenging ability (EC50 = 10.9 ± 0.7 µg/mL), a high
reducing power (EC50 = 32.2 ± 8.2 µg/mL), and effectively inhibited the oxidation of β-carotene
(EC50 = 2.4 ± 0.2 µg/mL). The extracts also showed NO• scavenging activity close to that of ascorbic
acid, and thus might be useful as anti-inflammatory agents. In addition, they exhibited antibacterial
activity against gram-negative and gram-positive bacteria. Staphylococcus aureus strains were the
most sensitive bacteria to thyme extracts, with minimum inhibitory concentration and minimum
bactericidal concentration values in the range of 0.6–3.5 mg/mL. Overall, this work is an important
contribution for the phytochemical characterization and the potential antioxidant, anti-inflammatory,
and antimicrobial activities of these three Thymus species, which have been poorly explored.
Keywords: thymus; thyme; LC-MS; mass spectrometry; phenolic; antioxidant; anti-inflammatory;
antiradicalar; antimicrobial activity
1. Introduction
The Thymus genus encloses about 350 species, which are particularly well adapted to the hot and
dry climate of the Mediterranean region and widespread in the arid parts of the Iberian Peninsula [1,2].
As for the vast majority of Lamiaceae plants, Thymus are recognized as being strongly aromatic and
are widely used as spices to enhance sensory attributes such as the taste and aroma of foods [1].
These properties highlight the potential application of Thymus plants in the food industry, e.g., in meat,
butter, chewing gum, liqueurs, ice cream, and candy production. Besides flavouring, their usage
also improves the preservation of food, contributing to the prevention of food oxidation and color
changes [3,4]. Likewise, these plants have some potential applications in pharmaceutical and cosmetic
industries due to their biological and medicinal benefits. They are largely used in the manufacturing
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of perfumes, pharmaceutical products, and toilet articles [4–7]. Although these applications have been
mostly associated with essential oils, nowadays, Thymus polar extracts are an attractive target for
the screening of health-promoting properties for possible industrial applications in food, cosmetics,
or pharmaceutical industries, among others [1,8].
Several authors have demonstrated that Lamiaceae, and particularly Thymus plants, are rich
in bioactive phytochemicals, including phenolic acids and flavonoids [1,3,9,10], which in turn,
have been shown to reduce the risk of diseases due to their extensive biological properties,
including those which are antioxidant, cardioprotective, anticancer, anti-ageing, anti-inflammatory,
and antibacterial [5,6,8,11].
The screening of the potential bioactive effects of Thymus polar extracts has been mainly
conducted for Thymus vulgaris [12–15] and Thymus serpyllum (wild thyme) [2,16], although other species,
including Thymus pulegioides [4,15], Thymus praecox [15], Thymus sipyleus [17], Thymus striatus [15],
Thymus longicaulis [15], Thymus mastichina [18], have also been studied with respect to their antioxidant
activities. Overall, aqueous or alcoholic extracts from Thymus have been shown to exhibit strong
antioxidant activities in in vitro [17,19] or in vivo models [20]. Moreover, other effects reported in the
polar extracts of thyme species include antimicrobial [21,22], antidiabetic [8,19], neuroprotective [15],
and inflammatory properties [23].
In contrast to the above mentioned studies, the potential applications of the polar extracts from
less-widespread Thymus like Thymus herba-barona, Thymus pseudolanuginosus, and Thymus caespititius
remain unexplored. These three species are particularly known for being well-adapted to the Atlantic
climate, thus growing spontaneously in the Iberian Peninsula and Mediterranean islands. As reported,
their essential oils exhibit antioxidant, antimicrobial, and insecticidal effects and can potentially be used
as preservatives in storage products for food flavouring, and as deodorants and disinfectants [24,25].
The present study aims to contribute to the clarification of phenolic constituents of T. herba-barona,
T. pseudolanuginosus, and T. caespititius, as well as to exploit their free radical scavenging, antibacterial,
and anti-inflammatory activities.
2. Results and Discussion
2.1. Phenolic Compounds in Thymus Aqueous Extracts
The mass yield of thyme aqueous extracts ranged from 15% to 20%, with T. caespititius being the
most predominant (Table 1). In turn, the latter showed a lower total phenolic content (236 ± 26.6 mg
GAE/g extract, equivalent to 47.0 mg GAE/g dry plant) in comparison to the mean values obtained for
the T. herba-barona and T. pseudolanuginosus extracts (273 and 293 mg GAE/g extract or 41.6 and 49.2 mg
GAE/g dry plant, respectively). However, it is important to note that these three aqueous extracts
had a considerably higher total phenolic content than those found by other authors in distinct Thymus
plants. In particular, aqueous extracts obtained from wild thyme (T. serpyllum) at 50 and 100ºC were
found to contain 79.02 ± 6.62 and 91.07 ± 9.25 mg GAE/g extract, respectively [16], while aqueous
extracts obtained from Thymus zygis leaves at 20ºC produced a 25.8 ± 2.0 mg GAE/g dry sample [3].
In addition, the phenolic content in phosphate buffer or hydromethanolic extracts from T. vulgaris
were reported to account for 2.1 ± 0.1 mg GAE/g fresh leaves [26] or 19.2 ± 0.3 mg GAE/g of fresh
weight [14], respectively.
Individual phenolic constituents of the three thyme aqueous extracts were elucidated by ultra
high performance liquid chromatography coupled to diode array detector and an a electrospray
mass spectrometer (UHPLC-DAD-ESI-MSn), taking into consideration the gathered ultraviolet-visible
(UV-Vis) and mass spectrometry (MS) spectra data of the eluted chromatographic peaks (Figure 1,
Table 2) and in comparison to those of standard compounds and/or in comparison to literature data.
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Table 1. Yield of extraction (%), total phenolic content (mg GAE/g of extract), and antioxidant and
anti-inflammatory activities (EC50, µg/mL) of T. herba-barona, T. pseudolanuginosus, and T. caespititius
aqueous extracts.
Plant Extract Yield (%) TPC DPPH• RP β-Carotene NO• 5-LOX
T. herba-barona 15.3 ± 1.80 a 273 ± 16.6 a,c 11.6 ± 0.90 a 35.1± 4.50 a >26.70 a 286 ± 32.6 a 841 ± 138 a
T. pseudolanuginosus 16.8 ± 0.90 a 293 ± 30.5 a 10.9 ± 0.70 a 32.2± 8.20 a 2.40 ± 0.20 b 299 ± 23.4 a 814 ± 87.2 a
T. caespititius 19.9 ± 2.40 a 236 ± 26.6 b,c 13.8 ± 0.60 a 39.3 ± 2.70 a 6.10 ± 0.20 c 230 ± 21.5 b 591 ± 166 a
AA 6.70 ± 0.70 b − 228 ± 20.7 b 7.80 ± 1.00 b
BHA − 16.0 ± 2.00 b 0.40 ± 0.02 d
Mean values ± standard deviations. Statistical analysis was performed by one-way ANOVA, followed by a Tukey
test. In each column, different letters (a–d) stand for significant statistical different data (p < 0.05). TPC: Total Phenolic
Compounds; RP: Reducing Power; AA: Ascorbic acid; BHA: Butylated hydroxyanisole; LOX: lipoxygenase.
Note that despite the fact that Thymus plants are generally known for their richness in
rosmarinic acid [1], the specific phenolic composition of thyme extracts is dependent on several
factors, including the botanical species and the applied extraction conditions. To the best of our
knowledge, there is no reported literature regarding the phenolic composition of T. herba-barona,
T. pseudolanuginosus, and T. caespititius extracts.
Rosmarinic acid was a major phenolic component in the three thyme extracts, accounting for
55.8 ± 2.8 mg/g in T. herba-barona and 40.2 ± 0.9 and 43.2 ± 3.2 mg/g in T. pseudolanuginosus
and T. caespititius, respectively. Despite the common abundance, rosmarinic acid was clearly less
representative in the T. pseudolanuginosus extract (30% of total quantified phenolics) in comparison
to the other two, in which it amounted for 45–52% of the total quantified phenolics. This difference
was mainly due to the high abundance of luteolin-O-glucuronide (6.8 min, [M − H]− at m/z 461→285)
in the T. pseudolanuginosus extract, which accounted for 54.1 ± 0.6 mg/g, while its levels were only
17.3 ± 1.1 mg/g and 4.4 ± 0.02 mg/g in the T. caespititius and T. herba-barona extracts, respectively.
Globally, the two O-glucuronide derivatives of luteolin eluted in fractions 15 and 16 (RT 6.8 and
7.0 min respectively) in the T. pseudolanuginosus extract accounted for 61.2 mg/g of the extract and
represented 46% of its total phenolics. This caused a clear differentiation between the extracts,
with T. pseudolanuginosus phenolic components being mainly represented by flavones. Note that
O-glucuronide derivatives of luteolin and other flavone glycosides such as luteolin-C-glucoside,
apigenin-O-glucuronide and apigenin-O-glucoside herein detected have also been previously described
for other Thymus species, but still, their levels, particularly those of luteolin-O-glucuronide derivatives,
are higher in T. pseudolanuginosus than in previously reported data (8–14 mg/g of dry plant) [1,17,27].
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Figure 1. Chromatographic profiles at 280 nm of T. herba-barona, T. pseudolanuginosus, and T. caespititius
aqueous extracts (The numbers in the figure correspond to the LC-MSn fractions indicated in Table 2).
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Table 2. Identification and quantification of UHPLC (ultra high performance chromatography) eluting fractions by UHPLC-DAD-MSn of T. herba-barona, T.
pseudolanuginosus, and T. caespititius aqueous extracts.
Fraction RT (min) λmax (nm) Compound [M-H]− Main Fragments ESI-MSn
(mg/g Extract)
T. h-b T. pseud T. caesp
1 1.3 270 Quinic acid A 191 MS2 [191]: 111, 173 D D D
2 1.6 278 Syringic acid-O-hex B 359 MS2 [359]: 197, 179, 161, 153, 135 D D D
3 1.8
281 Danshensu B 197 MS2 [197]: 179 D D D
292, 323 4-O-CQA B 353 MS2 [353]: 173, 179, 191 − D D
4 2.2 286, 322 t-5-O-CQA A 353 MS2 [353]: 191 , 179, 161, 135, 119 D 6.4 ± 0.4 D
5 2.4 271, 333 Apigenin di-C-glc B 593 MS2 [539]: 473, 353, 383, 503, 575, 297 D D 4.0 ± 0.2
6 3.3 289, 321 Caffeic acid A 179 MS2 [179]: 135, 151, 161, 107, 97 4.3 ± 0.1 D D
7 3.4
287, 318 SA F der B 375 MS2 [375]: 313, 269, 179, 135, MS3 [313]: 269, 161 D D D
277 RA der B 377 MS2 [377]: 359; MS3 [359]: 161, 179, 197, 223, 133 − − D
8 3.7 283 Eriodictyol-O-glc A 449 MS2 [449]: 287, 269, 259, 267 1.9 ± 0.01 − −
9 4.1 281, 342 Quercetin-O-glcA B 477 MS2 [477]: 301, 343, 397 2.3 ± 0.1 3.4 ± 0.04 1.1 ± 0.08
10 4.6 341 Luteolin-C-glc A 447 MS2 [447]: 357, 285, 327 5.1 ± 0.1 2.9 ± 0.02 −
11 5.1 282 RA sulfate B 439 MS2 [439]: 259, 421, 225, 371, 359, 197; MS3 [259]: 161 − − D
12 5.6 253, 287, 312 SA I B 537 MS2 [537]: 339, 493; MS3 [339]: 295, 229, 293 − D D
13 5.7 289, 318 SA F der B 519 MS2 [519]: 475, 313; MS3 [475]: 313, 269, 179, 431 D − −
14 6.2 254, 266, 345 Luteolin-O-rut B 593 MS2 [593]: 285 − − 2.2 ± 0.1
15 6.8 281, 331 Luteolin-O-glcA (isom 1) B 461 MS2 [461]: 285, 175; MS3 [285]: 267, 239, 241, 213, 185 4.4 ± 0.02 54.1 ± 0.6 17.3 ± 1.1
16 7.0 255, 265, 345 Luteolin-O-glcA (isom 2) B 461 MS2 [461]: 285; MS3 [285]: 241, 199, 175, 151, 267 10.5 ± 0.2 7.1 ± 0.2 6.8 ± 0.4
17 7.3 261, 331 Apigenin-O-glc (isom 1) A 431 MS2 [431]: 269 − 0.9 ± 0.15 −
18 8.0 285, 333 SA C der B 553 MS2 [553]: 491, 399, 179, 429, 473; MS3 [491]: 473 − D −
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Table 2. Cont.
Fraction RT (min) λmax (nm) Compound [M− H]− Main Fragments ESI–MSn (mg/g Extract)
T. h-b T. pseud T. caesp
19 8.3
254, 283, 344 SA B (isom1) B 717 MS2 [717]: 519, 475, 339; MS3 [519]: 475, 339 − − 6.9 ± 0.5
289, 318 Dedihydro-SA B (isom 1) B 715 MS2 [715]: 313, 627, 671, 269; MS2 [313]: 179, 135 10.8 ± 0.1 − −
20 8.5 289, 337 Chrysoeriol-O-glc B 461 MS2 [461]: 299, 284; MS3 [299]: 284 D D −
21 9.0 228, 282, 331 Apigenin-O-glc (isom 2) B 431 MS2 [431]: 269; MS3 [269]: 225, 149, 117, 183, 167, 199 D − −
22 9.0 252, 267, 342 Chrysoeriol-O-rut B 607 MS2 [607]: 299, 284 ; MS3 [299]: 284 − − D
23 9.1 267, 333 Apigenin-O-glcA B 445 MS2 [445]: 269, 175 2.1 ± 0.03 8.3 ± 0.05 1.97 ± 0.1
24 9.6 287, 325 RA A 359 MS2 [359]: 161, 179, 197, 223 55.8 ± 2.8 40.2 ± 0.9 43.2 ± 3.2
25 9.8 287, 311 3′-O-(8”-Z-Caffeoyl) RA (isom 1) B 537 MS2 [537]: 493, 515, 375, 357, 339, 313, 197 D D D
26 9.0 289, 319 Dedihydro- SA B (isom 2) B 715 MS2 [715]: 313, 671, 627, 269 D − −
27 10.1
288, 326 SA B (isom 2) B 717 MS2 [717]: 519, 357, 555 MS3 [519]: 357, 475, 295 D D D
287, 324 SA K B 555 MS2 [555]: 493, 357, 393, 313; MS3 [493]: 359, 313, 161 D 10.5 ± 0.1 −
28 10.7 290, 323 3′-O-(8”-Z-Caffeoyl) RA (isom 2) B 537 MS2 [537]: 493, 359; MS3 [493]: 359, 313, 295, 161 12.0 ± 0.2 D D
29 12.2 288, 322 Caffeoyl RA (isom 1) B 537 MS2 [537]: 375, 493, 359, 519 10.5 ± 0.06 D D
30 12.5 287, 328 Caffeoyl RA (isom 2) B 537 MS2 [537]: 439, 519, 357, 493, 323, 197 4.2 ± 0.1 − −
31 12.8 288, 323 Caffeoyl RA (isom 3) B 537 MS2 [537]: 519, 359, 357, 339, 235, 493; MS3 [519]: 357 − D −
32 13.3 287, 323 3′-O-(8”-Z-Caffeoyl) RA (isom 3) B 537 MS2 [537]: 493, 375, 359; MS3 [493]: 359, 197 D D D
Phenolic compounds groups
Caffeic acid and derivatives 97.6 ± 2.6 a 57.1 ± 1.3 b 50.0 ± 3.8 c
Flavones 22.0 ± 0.3 a 73.3 ± 1.0 b 32.2 ± 2.0 c
Flavonols 2.3 ± 0.1 a 3.6 ± 0.04 b 1.1 ± 0.1 c
Flavanones 1.9 ± 0.01 − −
Total 123.9 ± 2.8 a 134.0 ± 2.4 b 83.4 ± 5.8 c
T. h-b: Thymus herba-barona; T. pseud: Thymus pseudolanuginosus; T. caes: Thymus caespititius; D: detected; RT: retention time; CQA: caffeoylquinic acid; Der: derivative; Glc: glucoside; GlucA:
glucuronide; Hex: hexoside; isom: isomer; RA: rosmarinic acid; Rut: rutinoside; SA: salvianolic acid; A compound identification was based on comparison to standard; B compound
identification was based on interpretation of UV spectral and MS data, plus comparison to literature; Mean values ± standard deviations of three independent assays; Statistical analysis
was performed by one-way ANOVA (Tukey’s test). In each row, different letters (a–c) stand for significant statistical different data (p < 0.05).
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Apart from rosmarinic acid, the remaining caffeic acid derivatives represented 8%, 13%, and 34%
of the total quantified phenolic compounds in T. caespititius, T. pseudolanuginosus, and T. herba-barona
extracts, respectively. Among the three plant species, the latter was clearly the richest in this
group of compounds, comprising simple compounds, namely caffeic acid (4.3 ± 0.1 mg/g
extract) and t-5-O-CQA (in vestigial concentrations), as well as several depsides (Table 2), namely
3′-O-(8”-Z-caffeoyl)rosmarinic acid (a compound previously described in other thyme species [28])
and/or its isomers (MW 538 Da, fractions 25, 28 and 32), together with dihydro-salvianolic acid B
(fraction 19; MW 716 Da). On the other hand, salvianolic acids K (fraction 27, [M − H]− at m/z 555→
493→ 359) and B (fraction 19, [M−H]− at m/z 717→ 519→ 475) were found in the T. pseudolanuginosus
and T. caespititius extracts, with levels of 10.5 ± 0.1 and 6.9 ± 0.5 mg/g of the extract, respectively.
2.2. Antioxidant Capacity
The overproduction of oxidants is responsible for the pathogenesis of many chronic diseases.
In turn, distinct phytochemicals from foods and medicinal plants exhibit antioxidant properties
that might be beneficial to counteract oxidative events [11]. In this context, the three Thymus
aqueous extracts were investigated for their antioxidant abilities through distinct in vitro methods,
namely DPPH•, reducing power and β-carotene bleaching assays. The DPPH• scavenging method
evaluates the free radical scavenging ability of the plant extracts to trap the synthetic free radicals
DPPH•, while the reducing power and β-carotene bleaching methods measure the extract’s ability to
reduce Fe3+ to Fe2+ or to inhibit lipidic peroxidation, respectively.
The antioxidant potentialities of T. herba-barona, T. pseudolanuginosus, and T. caespititius aqueous
extracts are detailed in Table 1, in terms of their EC50 values. Considering the results, one can conclude
that all three Thymus extracts showed a high antioxidant capacity, which was particularly evident in
the DPPH• and reducing power tests, for which the EC50 values are 1.6–2.0 higher than those of the
reference commercial compounds. Among the three extracts, there is a tendency for the better activity
of T. pseudolanuginosus (EC50 of 10.9 ± 0.7 and 32.2 ± 8.2 µg/mL for DPPH• and reducing power tests,
respectively), although differences are not statistically significant.
The high antioxidant ability herein reported is in accordance with the literature data found
for Thymus plants. Indeed, low DPPH• EC50 values were previously registered for T. serpyllum L.
aqueous extracts (EC50 of 13.75 ± 1.14 and 11.76 ± 0.25 µg/mL for extracts obtained at 50 and 100 ◦C,
respectively) [16] and for the ethanolic extracts from T. longicaulis, T. praecox, T. pulegioides, T. serpyllum,
T. striatus, and T. vulgaris, which exhibited DPPH• EC50 values in the range of 3.01–6.01 µg/mL, i.e.,
1.8–3.6 higher than those of the reference commercial compounds [15]. Less promising results were
previously reported for Thymus capitatus methanolic and hexane extracts, with EC50 = 44.5 ± 1.9
and 38.2 ± 1.2 µg/mL, respectively (eight to nine times less active than the positive control
EC50 = 5.0 ± 0.8) [29] and for hydroalcoholic extracts from Thymus pubescens, Thymus kotschyanus,
and Thymus daenensis (EC50 range between 31.47 and 48.68 µg/mL), also six to nine times less active
that the positive control, i.e., galic acid [30]; for T. vulgaris and wild thyme infusions, the EC50 values
were 300 and 450 µg/mL, respectively, and corresponded to a 17–25 times lower efficacy than butylated
hydroxytoluene [12]. The ability of Thymus species to reduce Fe3+ to Fe2+ is not reported as often;
however, Kindl et al. have reported a strong ability for ethanolic extracts from T. longicaulis, T. praecox,
T. pulegioides, T. serpyllum, T. striatus, and T. vulgaris (EC50 = 11.4–15.1 µg/mL), with the best results
being registered for T. pulegioides, whose EC50 was only 1.7 higher than the reference control [15].
Contrary to the results of the above antioxidant methods, the three Thymus extracts presented clear
differences in the β-carotene bleaching assay. The oxidation of β-carotene was effectively inhibited by
T. pseudolanuginosus (EC50 = 2.4 ± 0.2 µg/mL), followed by T. caespititius (EC50 = 6.1 ± 0.2 µg/mL),
while T. herba-barona was ineffective (Table 1). Notably, literature data also point out promising activity
toward the β-carotene oxidation protection from other thymes. In particular, Iauk et al. [29] described
an EC50 value for a T. capitatus methanolic extract that was close to that of 0.7 ± 0.03 µg/mL in
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30 min and 1.9 ± 0.6 µg/mL in 60 min. Higher values were observed for the ethanolic extracts from
T. daenensis, T. kotschyanus, and T. pubescens (EC50 = 23.7, 35.2, and 92.9 µg/mL, respectively) [30].
The combined information from the three antioxidant methods, together with that from the
phenolic compounds´ levels, suggests that these last constituents are not the only actors dictating the
antioxidant potential of the extracts. Indeed, although phenolic compounds are abundant (particularly
flavones) in the T. pseudolanuginosus extract, which can be correlated to its superior antioxidant ability
in comparison to those of the remaining extracts, the direct phenolic content and antioxidant activity
were not observed for those of the two remaining plant species in the β-carotene bleaching assay.
This phenomenon could be due to the presence of oxidative—inducer components in the T. herba-barona
extract, thus mitigating the activity of the antioxidant phenolic compounds.
2.3. Anti-Inflammatory Activity
Because of the major relevance of inflammatory processes in the onset of numerous diseases
(cancer, Alzheimer, heart failure, ischemic stroke, and others), the search for low-toxic natural extracts
able to counteract pivotal inflammatory players has increased dramatically in the last years [31,32].
The aqueous extracts from the three plant species were screened for their ability to counteract two key
inflammatory events, namely the increment of NO• (i.e., a main proinflammatory mediator produced
by macrofages) and lipoxygenase (LOX) activity (i.e., the enzyme that controls the production of
proinflammatory leukotrienes) [7,33]. As detailed in Table 1, all the extracts revealed a high NO•
scavenging ability. Curiously, this effect was more evident for T. caespititius, which exhibited the
same potency as ascorbic acid (EC50 of 229.7 ± 21.5 µg/mL and 228.0 ± 20.7 µg/mL, respectively).
Despite having a low ability to inhibit LOX activity, T. caespetitius was also the most relevant amongst
the three samples (EC50 = 590.5 ± 166.3 µg/mL). Hence, the gathered results suggest that Thymus
aqueous extracts of the selected plants might have potential applications as anti-inflammatory
agents, acting through anti-radical capacities towards NO•. The fact that this ability is not directly
associated the extracts´ phenolic content (T. caespititius extract was the less rich in phenolics) also
suggests that non-phenolic compounds can have major roles in this action. To our knowledge,
the NO• scavenging ability of Thymus polar extracts has only been previously reported for ethanolic
extracts of six Thymus species: T. serpyllum subsp. serpyllum (EC50 = 176.6 ± 8.1 µg/mL),
T. praecox subsp. polytrichus (EC50 = 139.0 ± 5.7 µg/mL), T. vulgaris (EC50 = 97.9 ± 2.9 µg/mL),
T. striatus (EC50 = 91.1 ± 5.3 µg/mL), T. longicaulis (EC50 = 71.6 ± 4.9 µg/mL), and T. pulegioides
(EC50 = 69.8 ± 4.4 µg/mL) [15], which showed EC50 values 1.3–3.2 times higher than the tested
standard compound (Trolox), while that of LOX inhibition activity was not exploited.
2.4. Antibacterial Activity
The resistance to antibiotics has been associated with diseases and high mortality rates [34].
Research into new antimicrobial substances, such as purified natural compounds from plants, can serve
as one of the therapeutic strategies for the synthesis of new generation and alternative chemical
drugs with low toxicity. In this field, phenolic compounds have been gaining magnitude [35].
The antibacterial activity of the Lamiaceae family has been extensively studied, with promising
results being observed for Thymus essential oils [36,37], while little knowledge has been gathered
regarding polar extracts from a thyme origin.
Overall, the collected data showed that, among the five tested strains (Table 3), Staphylococcus
aureus was the most sensitive to the three Thymus extracts, which were able to inhibit both its growth
and viability at 0.6, 1.6, and 3.5 mg/mL for T. herba-barona, T. pseudolanuginosus, and T. caespititius,
respectively. These results are consistent with those reported for other Thymus species, such as in
the study described by Benbelaïd et al. for a water extract of Thymus lanceolatus, which exhibited a
minimum inhibitory concentration (MIC) value of 1.0 mg/ml for S. aureus, as evaluated by the broth
microdilution method [22]. Results acquired using the agar dilution method showed MIC values of
0.78 mg/ml for ethanolic extracts of Thymus caramanicus when exposed to S. aureus [21].
Int. J. Mol. Sci. 2017, 18, 1879 8 of 14
Table 3. MIC (mg/mL) and MBC (mg/mL) of plant extracts and nisin (mg/mL) against selected
test pathogens.
Bacteria
T. herba-barona T. pseudolanuginosus T. caespititius Nisin
MBC MIC MBC MIC MBC MIC MBC MIC
Salmonella typhimurium 5.0 5.0 >6.5 6.5 >7.0 7.0 0.5 0.5
Staphylococcus epidermidis 5.0 5.0 6.5 6.5 7.0 3.5 <0.03 <0.03
Staphylococcus aureus 0.6 0.6 1.6 1.6 3.5 3.5 0.25 0.25
Escherichia coli >5.0 5.0 >6.5 6.5 7.0 7.0 0.5 0.5
Pseudomonas aeruginosa >5.0 5.0 >6.5 6.5 >7.0 7.0 1.0 0.5
Mean values; MIC: minimum inhibitory concentration; MBC: minimum bactericidal concentration.
The three Thymus plants also exhibited a relevant antibacterial effect against the remaining
tested bacteria, although with less potency than the food preservative nisin. In detail, MIC values
of 5.0 and 6.5 mg/mL were registered for T. herba-barona and T. pseudolanuginosus, respectively,
against Salmonella typhimurium, Staphylococcus epidermidis, Escherichia coli, and Pseudomonas aeruginosa.
Despite T. caespititius generally being the less active extract, its activity towards S. epidermidis (MIC of
3.5 mg/mL) was more effective than the remaining ones. Note that the MIC concentrations herein
found are close to those previously reported for T. vulgaris ethanolic extracts, against the same panel
of bacteria (MIC in the range 6.25–12.5 mg/mL) [21] or to that of T. lanceolatus aqueous extracts
against S. typhimurium (MIC of 4.0 mg/mL) [22], although they are less effective than a T. caramanicus
hydroethanolic extract towards E. coli and P. aeruginosa (MIC values of 1.56 mg/mL and 1.30 mg/mL,
respectively) [21].
Overall, the gathered results showed that the thyme extracts were not lethal to some gram-negative
bacteria (S. typhimurium, E. coli, and P. aeruginosa), with a high minimum bactericidal concentration
(MBC) (Table 3). T. herba-barona is effective against S. typhimurium, but needs a concentration superior
to 5.0 mg/mL to kill E. coli and P. aeruginosa; a concentration of 6.5 mg/mL of T. pseudolanuginosus
was not effective against S. typhimurium, E. coli, and P. aeruginosa; T. caespititius can be lethal to E. coli,
but required a concentration superior to 7.0 mg/mL to eliminate S. typhimurium and P. aeruginosa).
Additionally, gram-negative bacteria were more resistant (MIC between 5.0 and 7.0 mg/mL) than
gram-positive bacteria, particularly S. aureus (MIC in the range 0.6 –3.5 mg/mL). These results
are in agreement with those of other authors, who tested aqueous extracts for T. lanceolatus
(MIC = 4.0 mg/mL against S. typhimurium and MIC = 0.83 mg/mL against S. aureus) [22]. The same
evidence was observed in several researches that tested oils extracted from Thymus plants [36,37].
3. Materials and Methods
3.1. Chemicals
Rosmarinic acid, apigenin-7-O-glucoside, luteolin-7-O-glucoside, eriodictyol-7-O-glucoside,
luteolin-8-C-glucoside, quinic acid, caffeic acid, and t-5-O-caffeoylquinic acid were obtained from
Extrasynthese (Genay Cedex, France). Gallic acid and nisin were obtained from Sigma Chemical Co.
(St. Louis, MO, USA). Folin-Ciocalteu reagent, Na2CO3, formic acid, and ethanol were purchased from
Panreac (Barcelona, Spain). n-hexane, methanol, and acetonitrile with HPLC purity were purchased
from Lab-Scan (Lisbon, Portugal). Mueller-Hinton agar was obtained from VWR, Prolabo Chemicals,
West Chester, PA, USA. Water was treated in a Direct-Q® water purification system (Merck Life
Science, Germany).
3.2. Plant Materials
T. herba-barona, T. caespititus, and T. pseudolanuginosus species were purchased as a mixture of
flowers, leaves, and stems from Ervital (Viseu, Portugal). The plants had been cultivated under an
organic regime and, after collection, their aerial parts (flowers, leaves, and stems) were dried in a
ventilated incubator at 20–35 ◦C, for three to five days.
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3.3. Extraction of Phenolic Compounds
Phenolic compounds were extracted by decoction, as according to Martins et al. [38],
thyme phenolic compounds are efficiently recovered by this methodology. Decoction was performed
according to the method described by Ferreira et al. [39], with adaptations. A total of 100 mL of
distilled water was added to 5 g of plant material (0.5 mm mesh powder) and the mixture was heated
and then boiled for 15 min. After extraction, the mixture was left to stand for 5 min, followed by
filtration under reduced pressure through a G3 sintered plates filter. The resulting filtrated solution
was concentrated in a rotary evaporator (BUCHI Labortechnik AG, Flawil, Switzerland) at 37 ◦C,
followed by deffating with n-hexane (1:1 v/v). The aqueous defatted fraction was frozen, freeze-dried,
and kept under vacuum in a desiccator in the dark, for subsequent use. Three extracts were obtained
for each plant.
3.4. Identification and Quantification of Phenolic Compounds
The total phenolic content of each Thymus extract was determined according to the adapted
Folin-Ciocalteu colorimetric method, as described by Pereira et al. [40]. The individual phenolic
compounds were identified by a UHPLC-DAD-ESI-MSn analysis of extracts (5 mg/mL), performed on
Ultimate 3000 (Dionex Co., Sunnyvale, CA, USA) apparatus equipped with an ultimate 3000 Diode
Array Detector (Dionex Co.) and coupled to a mass spectrometer. The chromatographic apparatus was
composed of a quaternary pump, an autossampler, a photodiode-array detector, and an automatic
thermostatic column compartment. The column used had a 100 mm length, 2.1 mm i.d., 1.9 µm particle
diameter, and end-capped Hypersil Gold C18 column (Thermo Scientific, Waltham, MA, USA), and its
temperature was maintained at 30 ◦C. Gradient elution was carried out with a mixture of 0.1% (v/v) of
formic acid in water (solvent A) and acetonitrile (solvent B), which were degassed and filtered before
use. The solvent gradient consisted of a series of linear gradients, starting with 15–28% of solvent B
over 5.6 min, increasing to 29% at 8.8 min, 100% of solvent B at 13.1 min, and maintaining this value up
to 17 min, followed by the return to the initial conditions, with a total running time of 20 min. The flow
rate used was 0.2 mL·min−1 and the UV–Vis spectral data for all peaks were accumulated in the range
200–600 nm. The chromatographic profiles were recorded at 280, 320, and 340 nm.
The mass spectrometer used was a Thermo LTQ XL (Thermo Scientific) ion trap MS equipped
with an ESI source. Control and data acquisition were carried out with the Thermo Xcalibur Qual
Browser data system (Thermo Scientific). Nitrogen above 99% purity was used and the gas pressure
was 520 kPa (75 psi). The instrument was operated in negative-ion mode with an ESI needle voltage
set at 5.00 kV and an ESI capillary temperature of 275 ◦C. The full scan covered the mass range from
m/z 100 to 2000. CID–MS/MS and MSn experiments were simultaneously acquired for precursor ions
using helium as the collision gas with a collision energy of 25–35 arbitrary units.
For quantitative analysis, the limits of detection (LOD) and quantification (LOQ) were calculated
from the parameters of the calibration curves obtained by an injection of known concentrations of the
exact or structurally-related standard compounds, represented in Table S1.
3.5. Bioactivity Tests
3.5.1. DPPH• Scavenging Test
The radical scavenging capacity of T. herba-barona, T. pseudolanuginosus, and T. caespititius extracts
was evaluated by a DPPH radical test, according to the previously described methodology [41].
Ascorbic acid was used as the positive control.
3.5.2. Reducing Power Test
The ability of T. herba-barona, T. pseudolanuginosus, and T. caespititius (0.05–0.25 mg/mL) aqueous
extracts in reducing iron (III) was assessed by the method previously described [41]. Butylated
hydroxyanisole (BHA) was used as the positive control.
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3.5.3. β-Carotene Bleaching Carotene
The assay was performed as previously described by Juntachote and Berghofer [42]. A stock
emulsion of β-carotene/linoleic acid was initially prepared by dissolving 20 mg of β-carotene in
10 mL of chloroform. A total of 1 mL of the β-carotene solution was added to 1 g of tween 80 and,
after chloroform removal, 50 mg of linoleic acid was added. Distilled water (100 mL) was added to the
mixture and homogenized using the rotary evaporator. Aliquots of β-carotene/linoleic acid emulsion
(250 µL) were mixed with 50 µL of extract at different concentrations and the initial absorbance at
470 nm was immediately recorded. After incubation at 50 ◦C for 2 h, the reaction was stopped using
an ice bath and the absorbance at 470 nm was measured. The blank used was prepared by adding
chloroform without β-carotene. BHA was used as the positive control. The % of inhibition was
calculated using the formula:
% of inhibition =
(Ct = 0 − Ct = 2)− (Et = 0 − Et = 2)
(Ct = 0 − Ct = 2) × 100
where Ct=0 corresponds to the absorbance of control at t = 0 min; Ct=2 corresponds to the absorbance of
control at t = 120 min; Et=0, Absorbance of extract at t = 0 min; Et=2, Absorbance of extract at t = 120 min.
3.5.4. NO• Scavenging Test
This assay was performed according to the method described by Bor et al. [43]. In brief, 100 µL of
sodium nitroprusside (3.33 mM) in PBS 100 mM (pH = 7.4) was added to 100 µL of extract solution
at different concentrations (0.07–0.5 mg/mL) and incubated for 15 min at room temperature under
light irradiation. The generated NO• interacts with molecular oxygen, producing NO2−, which in
the presence of 100 µL of Griess reagent (1% of sulfanilamide and 0.1% of naphthylethylenediamine
dihydrochloride in 2.5% of phosphoric acid) produces a purple azo dye. The measurement of the
absorbance was determined spectrophotometrically at 562 nm and ascorbic acid was used as the
positive control.
3.5.5. Inhibition of 5-Lipoxygenase
The LOX inhibitory assay was performed in a quartz 96-well plate according to the Tappel et al.
procedure, with some modifications [44]. During this procedure, 20 µL of the ascorbic acid or extract
sample solutions and 20µL of the LOX work solution were added to each well and incubated at
37 ◦C in the plate reader for 10 min. After incubation, 40 µL of linoleic acid, previously heated at
37 ◦C, was added and quickly placed in the plate reader. The reaction was followed for 20 min
taking measurements every minute at 234 nm. The reaction rate at each inhibitor concentration was
calculated by determining the slope of the experimental values and the percentage of inhibition by the
following formula:
% of inhibition =
v0 − v[inhibitor]
v0
× 100
where v0 corresponds to the reaction rate of control and v[inhibitor] is the reaction rate of the extract.
3.5.6. Antimicrobial Activity
The antibacterial potential of the Thymus polar extracts were evaluated against five bacterial
strains, including gram-positive bacteria (S. epidermidis NCTC 11047 and S. aureus NCTC 6571) and
gram-negative bacteria (S. typhimurium NCTC 12023, E. coli NCTC 9001, and P. aeruginosa NCTC 10662)
from the National Collection of Type Cultures, operated by Public Health England. All strains were
cultured in Mueller-Hinton agar and incubated at 37 ◦C for 24 h.
The MIC and MBC of plant extracts were determined by the broth microdilution method
using a modified standard protocol [45]. Bacterial suspensions were prepared by direct colony
suspensions in sterile distilled water and adjusted to obtain 1.5 × 108 colony-forming units (CFU)/mL,
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approximately equivalent to 0.5 McFarland units. A final inoculum of 1.5 × 105 CFU/mL was required
for suspensions diluted in a 1:100 ratio in Mueller-Hinton broth.
One hundred microliters of Mueller-Hinton broth was dispensed into wells of 96-well micro
titer plates (BioTek Instruments, Inc., Winooski, VT, USA). Aqueous solutions of T. herba-barona,
T. pseudolanuginosus, and T. caespititius extracts were added at a final concentration of 10, 13, and
14 mg/mL, respectively, and were then serially diluted four times across the plate. One hundred
microliters of bacteria suspension was finally added to each well and the plates were incubated at
37 ◦C for 24 h. The assay for each pathogen was repeated three times.
The MIC was defined as the lowest concentration at which visible growth was inhibited while the
MBC is the lowest concentration of the tested substance which has a bactericidal effect. MBC values
were determined by subculturing 10 µL of the culture from each negative well onto Mueller-Hinton
agar and then determining the dilution at which growth was detected [46].
The solvent without extracts served as the negative control and nisin was used as the positive
control. Nisin is an antibacterial polypeptide approved as a food preservative whose stock solution
was prepared by dissolving 2 mg of nisin in 1 mL of HCl 0.02 N [47].
3.6. Statistical Analysis
All data are presented as mean ± standard deviations. One-way analysis of variance (ANOVA)
followed by a Tukey’s test were used to detect any significant differences among different means.
A p-value of less than 0.05 was assumed to indicate a significant difference. The results were analyzed
using GraphPad Prism (GraphPad Software, CA, USA, version 6.0).
4. Conclusions
This work elucidates the phenolic composition of T. herba-barona, T. pseudolanuginosus,
and T. caespititius decoctions, whilst also exploiting their antioxidant, anti-inflammatory,
and antimicrobial activities. The three aqueous extracts were mainly characterized by the
presence of phenolic acids and flavonoids, which are in part related to their biological activities.
T. pseudolanuginosus presented the best antioxidant results concerning the three methods used.
The selected Thymus plants extracts exhibited antibacterial activity against the panel of tested bacteria
(S. typhimurium, S. epidermidis, S. aureus, E. coli, and P. aeruginosa ), especially S. aureus strains,
which were in general the most sensitive. T. caespititius appears to have anti-inflammatory potential,
based on its promising inhibitory activity on NO• production. Bearing in mind the increasing demand
for bioactive extracts of a botanical origin, this work opens a door for the expansion of the commercial
exploitation of the thyme species.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/18/9/1879/s1.
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